Biotech

All Articles

Cullinan, after $25M package, return bispecific to Harbour

.Cullinan Rehab was actually blown away enough along with Port BioMed's bispecific immune reactor th...

A more detailed consider Intense Biotech's Ferocious 15

.Within this week's incident of "The Best Pipe," we are actually diving in to Tough Biotech's annual...

Lilly experiences stage 2 breakdown of tau-targeting med

.The confetti is still flying coming from Eli Lilly's event celebrating the approval of Alzheimer's ...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings...

Lykos will ask FDA to reassess its selection observing rejection of MDMA treatment for post-traumatic stress disorder

.Adhering to a poor revealing for Lykos Therapies' MDMA candidate for post-traumatic stress disorder...

AN 2 fifty percents roll call, stops stage 3 test after information dissatisfy

.AN2 Therapies is reassessing its own service in action to uninspired midphase information, promisin...

Merck spends $700M for bispecific, spying autoimmune opening as well as odds to challenge Amgen in cancer

.Merck &amp Co. is actually paying out $700 thousand in advance to challenge Amgen in a blood cancer...

Gilead spends J&ampJ $320M to exit licensing offer for seladelpar

.With Gilead Sciences on the verge of an FDA decision for its liver disease medication seladelpar, t...

' All palms on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks can easily see the firms establishing outdoors tents at basecam...

Entero laying off team, moving out of office as well as pausing R&ampD

.Cushion Liquidators has actually switched Entero Therapies white colored as a sheet. The collector ...